nm61591's library 111 articles Export

Ordered by to_read.

	Correlation between cardiovascular disease and diabetes mellitus: current concepts. [My Copy] The American journal of medicine, Vol. 116 Suppl 5A (8 March 2004) by Richard W. Nesto posted to inflammation crp by nm61591 on 2009-08-20 14:29:13 as
	Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes. [My Copy] Diabetes/metabolism research and reviews, Vol. 25, No. 5. (July 2009), pp. 435-441. by Xiao-Ming M. Mao, Hao Liu, Xiao-Jun J. Tao, Guo-Ping P. Yin, Qian Li, Shu-Kui K. Wang posted to crp by nm61591 on 2009-08-20 14:17:13 as
	Glucose control and vascular complications in veterans with type 2 diabetes. [My Copy] The New England journal of medicine, Vol. 360, No. 2. (8 January 2009), pp. 129-139. by William Duckworth, Carlos Abraira, Thomas Moritz, et al.Domenic Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer Marks, Stephen N. Davis, Rodney Hayward, Stuart R. Warren, Steven Goldman, Madeline McCarren, Mary Ellen E. Vitek, William G. Henderson, Grant D. Huang, VADT Investigators posted to accord advance interventionaltrial mortality vadft by nm61591 on 2008-12-24 16:50:25 as along with 7 people and 1 group booker familydoc guhjy omalbam hmoffet richardh djmonstermo Anesthesia and Acute Pain
	Intensive Glycemic Control in the ACCORD and ADVANCE Trials. [My Copy] The New England journal of medicine (6 June 2008) by Robert G G. Dluhy, Graham T T. McMahon posted to accord review by nm61591 on 2008-12-14 20:24:44 as along with 4 people stempvoort timsenior guhjy booker
	Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. [My Copy] Lancet, Vol. 366, No. 9500. (26 November 2005), pp. 1849-1861. by A. Keech, R. J. Simes, P. Barter, et al.J. Best, R. Scott, M. R. Taskinen, P. Forder, A. Pillai, T. Davis, P. Glasziou, P. Drury, Y. A. Kesäniemi, D. Sullivan, D. Hunt, P. Colman, M. d'Emden, M. Whiting, C. Ehnholm, M. Laakso, posted to fenofibrate field by nm61591 on 2008-11-17 01:54:46 as
	Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. [My Copy] Circulation, Vol. 102, No. 1. (4 July 2000), pp. 21-27. posted to fibrate israeli by nm61591 on 2008-11-17 01:52:18 as
	Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. [My Copy] The New England journal of medicine, Vol. 341, No. 6. (5 August 1999), pp. 410-418. by H. B. Rubins, S. J. Robins, D. Collins, et al.C. L. Fye, J. W. Anderson, M. B. Elam, F. H. Faas, E. Linares, E. J. Schaefer, G. Schectman, T. J. Wilt, J. Wittes posted to gemfibrozil by nm61591 on 2008-11-17 01:49:47 as
	Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. [My Copy] The New England journal of medicine, Vol. 317, No. 20. (12 November 1987), pp. 1237-1245. by M. H. Frick, O. Elo, K. Haapa, et al.O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen posted to gemfibrozil helsinkiheart by nm61591 on 2008-11-17 01:44:05 as
	Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. [My Copy] Archives of internal medicine, Vol. 159, No. 22. (7 1999), pp. 2661-2667. by S. M. Haffner, C. M. Alexander, T. J. Cook, et al.S. J. Boccuzzi, T. A. Musliner, T. R. Pedersen, J. Kjekshus, K. Pyörälä posted to lipids by nm61591 on 2008-11-17 01:41:36 as
	MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. [My Copy] Lancet, Vol. 360, No. 9326. (6 July 2002), pp. 7-22. by Heart Protection Study Collaborative Group posted to lipids simvastatin by nm61591 on 2008-11-17 01:33:39 as along with 4 people Penquin007 aleeva journal06 mghim
	Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. [My Copy] Annals of internal medicine, Vol. 140, No. 8. (20 April 2004), pp. 650-658. by S. Vijan, R. A. Hayward, posted to lipids by nm61591 on 2008-11-17 01:26:41 as
	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. [My Copy] Lancet, Vol. 364, No. 9435. (7 2004), pp. 685-696. by H. M. Colhoun, D. J. Betteridge, P. N. Durrington, et al.G. A. Hitman, H. A. Neil, S. J. Livingstone, M. J. Thomason, M. I. Mackness, V. Charlton-Menys, J. H. Fuller, posted to atorvastatin lipids by nm61591 on 2008-11-17 01:23:48 as
	Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). [My Copy] Diabetes care, Vol. 28, No. 5. (May 2005), pp. 1151-1157. by P. S. Sever, N. R. Poulter, B. Dahlöf, et al.H. Wedel, R. Collins, G. Beevers, M. Caulfield, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, J. Ostergren posted to atorvastatin lipids by nm61591 on 2008-11-17 01:20:51 as
	Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. [My Copy] JAMA : the journal of the American Medical Association, Vol. 279, No. 20. (27 May 1998), pp. 1615-1622. by J. R. Downs, M. Clearfield, S. Weis, et al.E. Whitney, D. R. Shapiro, P. A. Beere, A. Langendorfer, E. A. Stein, W. Kruyer, A. M. Gotto posted to lipids lovastatin by nm61591 on 2008-11-17 01:18:13 as
	Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). [My Copy] Circulation, Vol. 97, No. 15. (21 April 1998), pp. 1440-1445. posted to lipids pravastatin by nm61591 on 2008-11-17 01:16:09 as
	Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. [My Copy] Lancet, Vol. 360, No. 9346. (23 November 2002), pp. 1623-1630. by J. Shepherd, G. J. Blauw, M. B. Murphy, et al.E. L. Bollen, B. M. Buckley, S. M. Cobbe, I. Ford, A. Gaw, M. Hyland, J. W. Jukema, A. M. Kamper, P. W. Macfarlane, A. E. Meinders, J. Norrie, C. J. Packard, I. J. Perry, D. J. Stott, B. J. Sweeney, C. Twomey, R. G. Westendorp, posted to lipids pravastatin by nm61591 on 2008-11-17 01:14:13 as
	Intensive versus moderate lipid lowering with statins after acute coronary syndromes. [My Copy] The New England journal of medicine, Vol. 350, No. 15. (8 April 2004), pp. 1495-1504. by Christopher P. Cannon, Eugene Braunwald, Carolyn H. McCabe, et al.Daniel J. Rader, Jean L. Rouleau, Rene Belder, Steven V. Joyal, Karen A. Hill, Marc A. Pfeffer, Allan M. Skene, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators posted to atorvastatin lipids pravastatin by nm61591 on 2008-11-17 01:02:10 as along with 2 people ggrassi djmonstermo
	Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 287, No. 24. (26 June 2002), pp. 3215-3222. by P. W. Serruys, P. de Feyter, C. Macaya, et al.N. Kokott, J. Puel, M. Vrolix, A. Branzi, M. C. Bertolami, G. Jackson, B. Strauss, B. Meier, posted to fluvastatin lipids by nm61591 on 2008-11-17 00:54:43 as
	Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. [My Copy] Diabetes, Vol. 48, No. 6. (June 1999), pp. 1289-1294. by B. J. Hoogwerf, A. Waness, M. Cressman, et al.J. Canner, L. Campeau, M. Domanski, N. Geller, A. Herd, A. Hickey, D. B. Hunninghake, G. L. Knatterud, C. White posted to lipids prospective by nm61591 on 2008-11-17 00:52:15 as
	Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. [My Copy] The New England journal of medicine, Vol. 339, No. 19. (5 November 1998), pp. 1349-1357. posted to lipids by nm61591 on 2008-11-17 00:50:12 as
	Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. [My Copy] Circulation, Vol. 98, No. 23. (8 December 1998), pp. 2513-2519. by R. B. Goldberg, M. J. Mellies, F. M. Sacks, et al.L. A. Moyé, B. V. Howard, W. J. Howard, B. R. Davis, T. G. Cole, M. A. Pfeffer, E. Braunwald posted to lipids pravastatin by nm61591 on 2008-11-17 00:44:50 as
	Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [My Copy] Lancet, Vol. 344, No. 8934. (19 November 1994), pp. 1383-1389. posted to 4s lipids simvastatin by nm61591 on 2008-11-15 23:37:13 as along with 1 person aleeva
	The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. [My Copy] JAMA : the journal of the American Medical Association, Vol. 251, No. 3. (20 January 1984), pp. 351-364. posted to cholestyramine lipids lrc-cppt by nm61591 on 2008-11-15 23:30:03 as
	Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines [My Copy] Circulation, Vol. 110, No. 2. (13 July 2004), pp. 227-239. by Scott M. Grundy, James I. Cleeman, Merz, et al.H. Bryan Brewer, Luther T. Clark, Donald B. Hunninghake, Richard C. Pasternak, Sidney C. Smith, Neil J. Stone, for the Coordinating Committee of the National Cholesterol Education Program, Lung Endorsed by the National Heart posted to lipids ncepatpiii by nm61591 on 2008-11-15 23:26:26 as along with 3 people dcvanpelt alanvelander R-MINI
	Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. [My Copy] Archives of internal medicine, Vol. 157, No. 2. (27 January 1997), pp. 181-188. by C. Abraira, J. Colwell, F. Nuttall, et al.C. T. Sawin, W. Henderson, J. P. Comstock, N. V. Emanuele, S. R. Levin, I. Pacold, H. S. Lee posted to interventionaltrial prospective vadft by nm61591 on 2008-11-15 23:22:34 as
	Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. [My Copy] Annals of internal medicine, Vol. 124, No. 1 Pt 2. (1 January 1996), pp. 104-109. by S. Genuth posted to intensivevsconventional interventionaltrial prospective ugdp by nm61591 on 2008-11-15 23:14:47 as
	Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. [My Copy] Eur Heart J, Vol. 26, No. 7. (April 2005), pp. 650-661. by K. Malmberg, L. Rydén, H. Wedel, et al.K. Birkeland, A. Bootsma, K. Dickstein, S. Efendic, M. Fisher, A. Hamsten, J. Herlitz, P. Hildebrandt, K. MacLeod, M. Laakso, C. Torp-Pedersen, A. Waldenström, posted to digami2 interventionaltrial prospective by nm61591 on 2008-11-15 23:12:08 as along with 2 people and 1 group booker worx11 XROWXR
	Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. [My Copy] Journal of the American College of Cardiology, Vol. 26, No. 1. (July 1995), pp. 57-65. by K. Malmberg, L. Rydén, S. Efendic, et al.J. Herlitz, P. Nicol, A. Waldenström, H. Wedel, L. Welin posted to digami interventionaltrial prospective by nm61591 on 2008-11-15 23:07:42 as along with 1 person booker
	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. [My Copy] Lancet, Vol. 352, No. 9131. (12 September 1998), pp. 837-853. posted to intensivevsconventional ukpds33 by nm61591 on 2008-11-15 23:00:55 as along with 5 people and 1 group booker guhjy journal06 mghim worx11 XROWXR
	Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. [My Copy] Annals of internal medicine, Vol. 141, No. 6. (21 September 2004), pp. 413-420. by K. T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, N. Day posted to a1c cvd mortality by nm61591 on 2008-11-15 22:54:15 as along with 1 person booker
	High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. [My Copy] Diabetes care, Vol. 21, No. 3. (March 1998), pp. 360-367. by B. Balkau, M. Shipley, R. J. Jarrett, et al.K. Pyörälä, M. Pyörälä, A. Forhan, E. Eschwège posted to helsinkipol independentriskfactor paris prospective whitehallstudy by nm61591 on 2008-11-15 21:22:17 as
	Dysglycaemia and risk of cardiovascular disease. [My Copy] Lancet, Vol. 347, No. 9006. (6 April 1996), pp. 949-950. by H. C. Gerstein, S. Yusuf posted to cvd by nm61591 on 2008-11-15 21:18:42 as
	Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. [My Copy] Journal of the American College of Cardiology, Vol. 33, No. 3. (March 1999), pp. 612-619. by H. C. Gerstein, P. Pais, J. Pogue, S. Yusuf posted to no-tag by nm61591 on 2008-11-15 21:16:45 as
	The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. [My Copy] Diabetes care, Vol. 22, No. 2. (February 1999), pp. 233-240. by M. Coutinho, H. C. Gerstein, Y. Wang, S. Yusuf posted to meta by nm61591 on 2008-11-15 20:57:00 as along with 1 person booker
	Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. [My Copy] Annals of internal medicine, Vol. 141, No. 6. (21 September 2004), pp. 421-431. by E. Selvin, S. Marinopoulos, G. Berkenblit, et al.T. Rami, F. L. Brancati, N. R. Powe, S. H. Golden posted to a1c cvd meta by nm61591 on 2008-11-15 20:54:20 as
	Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. [My Copy] Diabetes, Vol. 46, No. 8. (August 1997), pp. 1354-1359. by S. Lehto, T. Rönnemaa, S. M. Haffner, K. Pyörälä, V. Kallio, M. Laakso posted to cvd dyslipidemia by nm61591 on 2008-11-15 20:50:32 as
	Macrovascular disease and hyperglycaemia: 10-year survival analysis in Type 2 diabetes mellitus: the Belfast Diet Study. [My Copy] Diabetic medicine : a journal of the British Diabetic Association, Vol. 14, No. 8. (August 1997), pp. 663-672. by D. R. Hadden, C. C. Patterson, A. B. Atkinson, et al.L. Kennedy, P. M. Bell, D. R. McCance, J. A. Weaver posted to epidemiologic prospective survival by nm61591 on 2008-11-13 02:18:31 as
	The U.K. Prospective Diabetes Study. A review. [My Copy] Diabetes care, Vol. 21 Suppl 3 (December 1998) by R. C. Turner posted to review ukpds by nm61591 on 2008-11-13 02:11:16 as
	Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities [My Copy] Pharmacotherapy, Vol. 28, No. 2. (2008), pp. 193-206. posted to review by nm61591 on 2008-11-10 22:17:53 as
	Management of diabetes in cardiovascular patients [My Copy] Heart, Vol. 94, No. 3. (1 March 2008), pp. 369-375. by R. Peter, A. Cox, M. Evans posted to cvd review by nm61591 on 2008-11-10 21:09:33 as
	Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies [My Copy] The Lancet, Vol. 371, No. 9626., pp. 1800-1809. by Theodore Mazzone, Alan Chait, Jorge Plutzky posted to review riskfactor by nm61591 on 2008-11-10 21:01:42 as along with 1 person guhjy
	Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial [My Copy] The American Journal of Cardiology, Vol. 99, No. 12. (18 June 2007), pp. S80-S89. by D. Bonds, E. Kurashige, R. Bergenstal, et al.D. Brillon, M. Domanski, J. Felicetta, V. Fonseca, K. Hall, I. Hramiak, M. Miller posted to accord hypoglycemia interventionaltrial by nm61591 on 2008-11-07 19:34:25 as
	Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial [My Copy] The American Journal of Cardiology, Vol. 99, No. 12. (18 June 2007), pp. S56-S67. by H. Ginsberg, D. Bonds, L. Lovato, et al.J. Crouse, M. Elam, P. Linz, P. Oconnor, L. Leiter, D. Weiss, E. Lipkin posted to accord interventionaltrial lipids by nm61591 on 2008-11-07 19:31:19 as
	Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein [My Copy] N Engl J Med, Vol. 359, No. 21. (20 November 2008), pp. 2195-2207. by Paul M. Ridker, Eleanor Danielson, Francisco A. H. Fonseca, et al.Jacques Genest, Antonio M. Gotto, John J. P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. MacFadyen, Borge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn, the JUPITER Study Group posted to jupiter inflammation crp by nm61591 on 2009-08-21 15:17:19 as along with 6 people timsenior lula guhjy djmonstermo shoshin fkz1
	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [My Copy] The New England journal of medicine, Vol. 347, No. 20. (14 November 2002), pp. 1557-1565. by Paul M. Ridker, Nader Rifai, Lynda Rose, Julie E. Buring, Nancy R. Cook posted to crp by nm61591 on 2009-08-21 15:05:58 as
	C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. [My Copy] The New England journal of medicine, Vol. 342, No. 12. (23 March 2000), pp. 836-843. by P. M. Ridker, C. H. Hennekens, J. E. Buring, N. Rifai posted to inflammation cytokines crp biomarkers by nm61591 on 2009-08-21 15:04:02 as
	Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. [My Copy] The New England journal of medicine, Vol. 336, No. 14. (3 April 1997), pp. 973-979. by P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, C. H. Hennekens posted to inflammation cvd by nm61591 on 2009-08-21 15:01:39 as
	Inflammatory markers and risk of developing type 2 diabetes in women. [My Copy] Diabetes, Vol. 53, No. 3. (March 2004), pp. 693-700. by Frank B. Hu, James B. Meigs, Tricia Y. Li, Nader Rifai, JoAnn E. Manson posted to inflammatory cytokines biomarkers by nm61591 on 2009-08-21 14:58:13 as
	C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. [My Copy] Diabetes, Vol. 51, No. 5. (May 2002), pp. 1596-1600. by Dilys J. Freeman, John Norrie, Muriel J. Caslake, et al.Allan Gaw, Ian Ford, Gordon D. Lowe, Denis St S. O'Reilly, Chris J. Packard, Naveed Sattar, West of Scotland Coronary Prevention Study posted to crp by nm61591 on 2009-08-21 14:55:09 as along with 1 person booker
	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. [My Copy] Diabetes, Vol. 51, No. 4. (April 2002), pp. 1131-1137. by Andreas Festa, Ralph D'Agostino, Russell P. Tracy, Steven M. Haffner, Insulin Resistance Atherosclerosis Study posted to cytokines biomarkers by nm61591 on 2009-08-21 14:53:07 as

Note: You may cite this page as: http://www.citeulike.org/user/nm61591/order/to_read

Result page: 1 2 3 Next

lipids	20
cvd	18
prospective	16
interventionaltrial	13
crp	11
riskfactor	11
accord	10
cytokines	10
review	10
epidemiologic	9
inflammation	8
independentriskfactor	7
biomarkers	5
advance	4
atorvastatin	4
inflammatory	4
pravastatin	4
intensivevsconventional	3
israeli	3
meta	3
microalbumin	3
vadft	3
a1c	2
betacell	2
digami	2
fenofibrate	2
gemfibrozil	2
insulin	2
insulinresistance	2
mortality	2
simvastatin	2
survival	2
whitehallstudy	2
4s	1
cholestyramine	1
cost	1
dais	1
dcct	1
dcctedic	1
digami2	1
dyslipidemia	1
fibrate	1
field	1
file-import-08-12-24	1
fluvastatin	1
followup	1
frammingham	1
gusto1	1
helsinkiheart	1
helsinkipol	1
hope	1
hypoglycemia	1
il6	1
jncvi	1
jupiter	1
kumamoto	1
lovastatin	1
lrc-cppt	1
microvascular	1
ncepatpiii	1
oasis	1
paris	1
postprandial	1
proinflammatory	1
ranchob	1
retinopathy	1
retrospective	1
sprint	1
steno2	1
ugdp	1
ukpds	1
ukpds33	1
ukpds35	1
ukpds36	1
ukpds80bg	1
ukpds80bp	1
vadt	1

nm61591's library 111 articles Export

nm61591's tags